CGLO Coro Global
Hash Labs Inc. is a Nevada corporation that was originally formed on November 1, 2005 when Bio-Solutions International Inc. (“Bio-Solutions”) entered into an Agreement and Plan of Merger with OmniMed Acquisition Corp., a Nevada corporation and a wholly-owned subsidiary of Bio-Solutions, OmniMed International Inc. (“OmniMed”) and the shareholders of OmniMed. On January 17, 2006, OmniMed changed its name to MedeFile International Inc. The Company’s business following the closing of this agreement was the sale of an Internet-enabled Personal Health Record (iPHR) system for gathering, digitizing, maintaining, accessing and sharing an individual’s medical records, and in connection therewith, providing a professional service specializing in HIPAA compliant retrieval, reproduction and release of information. Under this service, Company personnel went onsite to physicians’ offices weekly to reproduce the records requested by third parties.
Company profile
Ticker
CGLO
Exchange
Website
CEO
J. Mark Goode
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Microsoft • Oracle • Activision Blizzard • BlackBerry • NortonLifeLock • Adobe • Vmware • Ceridian HCM Holding • McAfee • SolarWinds ...
Former names
BIO SOLUTIONS INTERNATIONAL INC, Hash Labs Inc., Medefile International, Inc., OMNIMED INTERNATIONAL, INC., SEPTIMA ENTERPRISES INC, Tech Town Holdings Inc.
SEC CIK
Corporate docs
IRS number
850368333
CGLO stock data
()
Investment data
Securities sold
Number of investors
Calendar
31 Mar 21
13 Apr 21
31 Dec 21
Financial summary
Quarter (USD) |
Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial data from Coro Global earnings reports.
Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 583.83K | 583.83K | 583.83K | 583.83K | 583.83K | 583.83K |
Cash burn (monthly) | 270.91K | (positive/no burn) | 463.32K | 446.12K | 282.79K | 269.85K |
Cash used (since last report) | 930.67K | n/a | 1.59M | 1.53M | 971.51K | 927.03K |
Cash remaining | -346.85K | n/a | -1.01M | -948.76K | -387.68K | -343.21K |
Runway (months of cash) | -1.3 | n/a | -2.2 | -2.1 | -1.4 | -1.3 |
Institutional ownership Q3 2020
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
13F holders |
Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares |
Current |
---|---|
Total value | 0 |
Total shares | 0 |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners |
Shares | Value |
---|
Financial report summary
?Competition
PayPalManagement Discussion
- In August 2020 the Company successfully launched the Coro mobile payment application on a commercial basis. The Coro app is available for users to download in the Apple Store and Google Play. The Company generated nominal transaction revenues of $694 during the year ended December 31, 2020.
- Selling, general and administrative expenses for the year ended December 31, 2020 were $4,269,390, an increase of $433,842 or approximately 10% compared to selling, general and administrative expenses of $3,835,548 for the year ended December 31, 2019. The increase in expense was mainly attributable to higher legal, professional and consulting fees during the year ended December 31, 2020. In addition, during the year ended December 31, 2020 the Company incurred advertising costs of $295,538 compared to $8,994 for the year ended December 31, 2019, as the Company prepared to launch its CORO product. This was partially offset by a decrease in stock compensation due to consulting fees of $1,300,163 to $1,417,128 for the year ended December 31, 2020 from stock compensation expense of $2,717,291 for the year ended December 31, 2019.
- Development expenses for the year ended December 31, 2020 were $1,084,705 compared to $997,620 for the year ended December 31, 2019. We incurred higher development expenses, including fees paid to vendors, for our CORO product during the year ended December 31, 2020 compared to the year ended December 31, 2019 as we expanded development of our CORO product.
Content analysis
?
Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
acceleration, AG, Alabama, Alaska, Angella, Apple, Arizona, Asia, Australia, BA, Batten, behavioral, belong, Benjamin, Brazil, career, Cayman, Chicago, chosen, Columbia, component, COO, cyber, Dakota, Darden, decade, dedicated, Delaware, democratize, demonstrate, deploy, District, drop, effectuated, electronic, embarked, enthusiasm, exceeding, experimentation, exponential, feedback, Fellow, fit, Fligoo, formation, friction, FX, garnering, Georgia, Google, half, headed, headquartered, Idaho, India, interface, Iowa, Island, Jersey, journey, Joyce, Kingdom, Latin, lifetime, longevity, Lou, macroeconomic, maximize, Mercantile, microinsurance, mindshare, Minnesota, Mississippi, mode, momentum, Montana, move, Mutual, Naser, nationwide, Naupari, offset, Ohio, operationally, optimization, optimize, optimizing, Oregon, OTCQB, ParaLife, partially, Payout, people, pillar, pivoted, Play, PR, proposition, Puerto, ready, remote, remotely, Rhode, Rico, Rocket, Rudolf, San, School, Seymour, simple, society, St, Summary, Swirld, Switzerland, thought, traction, UBS, underprivileged, Unearned, Unexercised, unpredictable, VARIV, vision, waiting, Wall, widespread, Wisconsin, Zurich
Removed:
accessing, accessory, assessing, Assistant, auto, Black, body, borrowed, car, closing, compliant, copy, coupled, debenture, derivative, digitizing, embedded, entrepreneur, evaluate, exotic, fostering, freestanding, front, fueled, Health, Hedging, HIPAA, identifying, innovation, investor, iPHR, largely, licensing, mailing, manager, Maryland, medefile, medical, Merger, narrow, occurred, OmniMed, onsite, operational, page, Pink, prudent, ranging, representing, reproduce, reproduction, request, requested, retrieval, reviewed, settle, sum, tech, therewith, town, unsecured, utilize, variable, viewing
Financial reports
10-K
2020 FY
Annual report
31 Mar 21
10-Q
2020 Q3
Quarterly report
23 Nov 20
NT 10-Q
Notice of late quarterly filing
16 Nov 20
10-Q
2020 Q2
Quarterly report
10 Aug 20
10-Q
2020 Q1
Quarterly report
15 May 20
10-K
2019 FY
Annual report
13 Apr 20
NT 10-K
Notice of late annual filing
30 Mar 20
10-Q
2019 Q3
Quarterly report
15 Nov 19
NT 10-Q
Notice of late quarterly filing
15 Nov 19
10-Q
2019 Q2
Quarterly report
14 Aug 19
Current reports
8-K
Entry into a Material Definitive Agreement
21 Jan 21
8-K
Departure of Directors or Certain Officers
31 Dec 20
8-K
Regulation FD Disclosure
17 Nov 20
8-K
Changes in Registrant's Certifying Accountant
17 Sep 20
8-K
Unregistered Sales of Equity Securities
11 Sep 20
8-K
Entry into a Material Definitive Agreement
9 Jul 20
8-K
Entry into a Material Definitive Agreement
30 Jun 20
8-K
Entry into a Material Definitive Agreement
28 Jun 20
8-K
Entry into a Material Definitive Agreement
24 Jun 20
8-K
Other Events
10 Jun 20
Registration and prospectus
S-1/A
IPO registration (amended)
25 Jan 21
D/A
$10M in equity, sold $5.93M, 68 investors
31 Aug 20
S-1
IPO registration
11 May 20
424B3
Prospectus supplement
12 Feb 20
S-1/A
IPO registration (amended)
24 Jan 20
S-1/A
IPO registration (amended)
30 Jul 19
D
$10M in equity, sold $25K, 1 investor
12 Feb 19
S-1/A
IPO registration (amended)
3 Jan 19
S-1
IPO registration
29 Oct 18
D
$1M in equity, sold $766.67K, 3 investors
23 Aug 18
Other
EFFECT
Notice of effectiveness
10 Feb 20
CORRESP
Correspondence with SEC
4 Feb 20
CORRESP
Correspondence with SEC
15 Dec 19
CORRESP
Correspondence with SEC
28 Oct 19
UPLOAD
Letter from SEC
28 Aug 19
CORRESP
Correspondence with SEC
29 Jul 19
UPLOAD
Letter from SEC
25 Apr 19
CORRESP
Correspondence with SEC
31 Mar 19
UPLOAD
Letter from SEC
15 Aug 11
CORRESP
Correspondence with SEC
14 Aug 11